ATE342059T1 - Verwendung zur verabreichung von östrogen - Google Patents

Verwendung zur verabreichung von östrogen

Info

Publication number
ATE342059T1
ATE342059T1 AT95929349T AT95929349T ATE342059T1 AT E342059 T1 ATE342059 T1 AT E342059T1 AT 95929349 T AT95929349 T AT 95929349T AT 95929349 T AT95929349 T AT 95929349T AT E342059 T1 ATE342059 T1 AT E342059T1
Authority
AT
Austria
Prior art keywords
estrogen
administration
glycoside
menopause
alleviation
Prior art date
Application number
AT95929349T
Other languages
English (en)
Inventor
Michael F Holick
Original Assignee
Michael F Holick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael F Holick filed Critical Michael F Holick
Application granted granted Critical
Publication of ATE342059T1 publication Critical patent/ATE342059T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95929349T 1994-08-04 1995-08-03 Verwendung zur verabreichung von östrogen ATE342059T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/285,438 US5612317A (en) 1994-08-04 1994-08-04 Method for delivering estrogen

Publications (1)

Publication Number Publication Date
ATE342059T1 true ATE342059T1 (de) 2006-11-15

Family

ID=23094228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95929349T ATE342059T1 (de) 1994-08-04 1995-08-03 Verwendung zur verabreichung von östrogen

Country Status (7)

Country Link
US (1) US5612317A (de)
EP (1) EP0894000B1 (de)
AT (1) ATE342059T1 (de)
CA (1) CA2226140C (de)
DE (1) DE69535267T2 (de)
ES (1) ES2274519T3 (de)
WO (1) WO1996003995A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087420B1 (en) 1997-07-17 2006-08-08 Cambia Microbial β-glucuronidase genes, gene products and uses thereof
US6391547B1 (en) * 1997-09-09 2002-05-21 Center For The Application Of Molecular Biology To International Agriculture Microbial β-glucuronidase genes, gene products and uses thereof
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
CZ20013912A3 (cs) * 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
AU7673900A (en) * 1999-10-08 2001-04-23 Strakan Limited Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof
WO2001027127A1 (en) * 1999-10-08 2001-04-19 Strakan Group Plc Tamoxifen and tamoxifen analogue glycosides and uses thereof
ATE400580T1 (de) * 2001-08-21 2008-07-15 Glycomed Sciences Ltd Chemische synthese von solamargin
EP1487460A2 (de) 2002-02-28 2004-12-22 A & D Bioscience, Inc. Glycuronamide, glycoside und orthoester-glycoside von fluoxetin, analoga und ihre verwendungen
DE10238390A1 (de) * 2002-08-16 2004-02-26 Stern, René Medizinisches Versorgungs- und Transportmodul
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078060A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of inducing an estrogenic response
US4096254A (en) * 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
US4410515A (en) * 1981-04-01 1983-10-18 Massachusetts General Hospital Vitamin D glycosides and a method of use
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters
HU214598B (hu) * 1987-09-24 1998-04-28 Jencap Research Ltd Eljárás fogamzásgátló és hormonterápiához alkalmazható, ösztrogént és progesztint tartalmazó gyógyszerkészítmények előállítására
EP0322020A1 (de) * 1987-12-22 1989-06-28 Akzo N.V. Pharmazeutische Dosierungseinheit zur Behandlung von klimakterischen Beschwerden und Osteoporosis
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product

Also Published As

Publication number Publication date
US5612317A (en) 1997-03-18
DE69535267T2 (de) 2007-05-24
WO1996003995A1 (en) 1996-02-15
CA2226140A1 (en) 1996-02-15
EP0894000A4 (de) 2001-04-04
EP0894000A1 (de) 1999-02-03
DE69535267D1 (de) 2006-11-23
CA2226140C (en) 2001-10-23
ES2274519T3 (es) 2007-05-16
EP0894000B1 (de) 2006-10-11

Similar Documents

Publication Publication Date Title
DE69914726D1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
ATE281170T1 (de) Verwendung von steroiden zur behandlung von asthma und atemwegerkrankungen
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
YU7797A (sh) Kombinovana terapija za osteoporozu
AP9801269A0 (en) Prostaglandin agonists.
DE69521521D1 (de) Mono- oder polyfunktionelle konjugate von polylysine
IL110943A0 (en) Compositions for the treatment of skin disorders
MX9606404A (es) Composiciones farmaceuticas y metodos para formular trasnduccion de señales.
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
EP0975351A4 (de) Behandlung der multiplen sklerose durch einnahme oder inhalation von copolymer-1
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
DE69535267D1 (de) Verwendung zur verabreichung von östrogen
ATE171873T1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
IL143516A0 (en) COMPOUNDS AND METHODS FOR MODULATING ACTIVATION OF NF-k-B
MY120530A (en) Combination preparation for use in dementia
DE69606321T3 (de) Verwendung von 2-Ethylhexyl-alpha-cyano-beta, beta-diphenylacrylat zur Verbesserung der Lichtstabilität von p-Methylbenzylidencampher
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE69418931D1 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties